StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.92−0.09 (-8.88%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Cellectar Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cellectar Biosciences's pe ratio was 1.5× on Jan 31, 2017.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jan 31, 20171.5×+0.4
2016Dec 30, 20161.1×–

More Cellectar Biosciences figures

See a number that looks wrong?